Correction: Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis / R. Mokhtari, B. Qorri, N. Baluch, A. Sparaneo, F. Fabrizio, L. Muscarella, A. Tyker, S. Kumar, H. Cheng, M. Szewczuk, B. Das, H. Yeger. - In: ONCOTARGET. - ISSN 1949-2553. - 13:1(2022), pp. 968-969. [10.18632/oncotarget.28104]
Correction: Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis
F. Fabrizio;
2022
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
oncotarget-13-28104.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
1.6 MB
Formato
Adobe PDF
|
1.6 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
